NASDAQ: TNDMTandem Diabetes Care Revenue
Tandem Diabetes Care revenue was $1.01B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $249.3M, up 3.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNDM annual revenue was $940.2M, with 25.7% growth year-over-year.
TNDM past revenue growth
How has TNDM's revenue growth performed historically?
Company
17.87%
Industry
11.03%
Market
22.05%
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNDM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
TNDM revenue history
Current Revenue
$1.0B
Current Earnings
-$203.4M
Current Profit Margin
-20.2%
Be the first to know when TNDM announces revenue.
TNDM Revenue History By Year
| TNDM Yearly Revenue | TNDM Revenue | TNDM Change | TNDM Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $940.20M | $192.49M | +25.74% |
| 2023-12-31 | $747.72M | -$53.50M | -6.68% |
| 2022-12-31 | $801.22M | $98.42M | +14.00% |
| 2021-12-31 | $702.80M | $203.97M | +40.89% |
| 2020-12-31 | $498.83M | $136.53M | +37.68% |
| 2019-12-31 | $362.31M | $178.44M | +97.05% |
| 2018-12-31 | $183.87M | $76.27M | +70.88% |
| 2017-12-31 | $107.60M | $23.35M | +27.72% |
| 2016-12-31 | $84.25M | $11.40M | +15.65% |
| 2015-12-31 | $72.85M | $23.13M | +46.51% |
| 2014-12-31 | $49.72M | $20.72M | +71.41% |
| 2013-12-31 | $29.01M | $26.53M | +1,072.00% |
| 2012-12-31 | $2.48M | N/A | N/A |
| 2011-12-31 | $0.00 | N/A | N/A |
Tandem Diabetes Care Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.